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Despite being one of Asia’s major economies with a population of over 23 million, Taiwan 
has been mostly excluded from the World Health Assembly/World Health Organization 
(WHA/WHO) since 1972, due to China’s objection. While this has not stopped Taiwan from 
developing a comprehensive healthcare system and being an active member of international 
health community, the lack of membership in the world’s leading health authority 
undermines global health and presents perverse, and yet often neglected, inequality faced by 
Taiwanese people. This article aims to provide contextual information concerning the impacts 
of Taiwan’s exclusion from WHA/WHO by: (1) enumerating health-related areas where 
Taiwan has rich knowledge and experiences that would have been cascaded much more 
widely and efficiently to those in need around the world had it been allowed to participate; 
and (2) highlighting difficulties faced by Taiwanese people and potential threats to 
international health arising from the exclusion. 
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With a population of over 23 million, Taiwan is one of Asia’s major economies. Despite 
being an active member of the international community in every respect, Taiwan has been 
excluded from the United Nations (UN) and its associated organisations since 1970s, when 
People’s Republic of China gained the UN’s recognition as the representative of China in 
place of the Republic of China. Among the many UN-associated organisations which provide 
leadership and promote collaboration in almost every aspect of international affairs is the 
World Health Organization (WHO), a specialised agency established in 1948 under the 
Charter of the UN with the objective of the ‘attainment of all peoples of the highest possible 
level of health’ and a guiding principle that this should be ‘fundamental rights of every 
human being without distinction of race, religion, political belief, economic or social 
condition’ (WHO, 2006). The World Health Assembly (WHA) is WHO’s decision body. It is 
convened annually in Geneva and is attended by delegations from all WHO member states. 
The WHA appoints WHO’s director-general, determines its policies and work programmes, 
supervises its finance, and provides a forum for discussion and debate of issues related to 
health. 
 
The exclusion of Taiwan from the UN means it has also been excluded from the WHO, and 
by extension participation in the WHA. Despite repeated attempts by Taiwanese medical 
professions and government to obtain membership to WHO and to gain access to WHA, 
Taiwan was only allowed to participate in the WHA as an observer under the title of ‘Chinese 
Taipei’ between 2009 to 2012. Even such restricted access turned out to be short-lived and 
was conditional upon China’s subjugation of Taiwan’s status. This means Taiwan has been 
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prevented from joining the world’s leading authority and prime forum for health, against its 
will, due to political reasons. 
 
This article aims to provide contextual information with regard to the impacts of Taiwan’s 
exclusion from the perspectives of health services and research—which both concern the 
promotion of health, the ultimate goal for WHO/WHA. Evidence on Taiwan’s major 
contribution towards improving the health of its population and the wider world, despite its 
absence from WHA/WHO, is presented to illustrate the perverse restrictions that prevent 
Taiwan from officially participating in international health affairs, as well as to highlight 
areas where Taiwan could have more direct and wider contribution towards other countries. 
Attention is also drawn to the difficulties and threats that people in Taiwan face because of 
their exclusion from the WHO/WHA. Information included in this article is gathered from 
searches of biomedical and health sciences literature, supplemented by personal knowledge 
and experiences in academic research and healthcare policy, as well as by discussions of 
pertinent issues with colleagues. The intention is to provide a descriptive account of factual 
information directly related to health service provision and research to set the scene for 
further discourse of Taiwan’s participation in the WHA/WHO. The author acknowledges the 
complex historical and sociopolitical issues surrounding Taiwan’s membership for 
WHO/WHA, and it is beyond this article’s remit to undertake in-depth analyses of empirical 
evidence to explicate reasons behind Taiwan’s difficulties in obtaining membership, which 
warrants a separate endeavour. The author also deliberately refrains from delving into 
theoretical development and conceptual debates, which can be found in accompanying 
articles in this issue of the journal and elsewhere (see Herington & K. Lee, 2014; Hickey, 
2006; K. Lee & Fang, 2016). 
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Taiwan and International Health 
Health is regarded as a human right as it affects every aspect of a person’s life and well-
being. Maintaining good health requires both: (1) sufficient socioeconomic resources to fulfil 
people’s basic needs and to promote behaviours and an environment that have positive 
influences on determinants of health; and (2) a well-functioning healthcare system to prevent 
ill health and to help people recover from or manage illnesses when they occur. Taiwan’s 
successful transformation from a low-income economy to one of the ‘four little dragons’ in 
Asia in the late twentieth century is a unique experience which can be shared with developing 
countries in its own right (Vogel, 1991). This article centres on issues directly related to 
health services and health research, which are most relevant to the function of the 
WHA/WHO. 
 
Three topic areas are chosen as the focus of the narrative: health system and services; 
infectious disease control and prevention; and biomedical research. These topic areas are 
characterised by their major impact on health, the existence of substantial achievement made 
and ongoing challenges faced by people in Taiwan, and the inextricable relationship between 
Taiwan and rest of the world. 
 
Taiwan’s Health System and Services 
 
1. Universal Coverage of Healthcare 
Back in 1978, world leaders and health experts gathered in Almaty, Kazakhstan (formerly 
part of the USSR), and adopted the Declaration of Alma-Ata at the International Conference 
on Primary Health Care. The declaration affirmed that health is a fundamental human right 
and was considered as a major milestone in public health in the twentieth century. It 
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highlighted the gross inequality in the health status of people, particularly between 
developing and developed countries, and urged all countries to ‘collaborate in spirit of 
partnership’ (International Conference on Primary Health Care, 1978) and called for WHO, 
the United Nations International Children’s Emergency Fund (UNICEF), and governments 
and non-governmental organisations at all levels to take initiatives to support the 
development of primary healthcare that is accessible and affordable to all individuals and 
families when they need it. Forty years on, this noble aspiration remains a major challenge 
for many countries around the world. The UN has reaffirmed its commitment to facilitating 
universal health coverage in the Sustainable Development Goals it adopted in its General 
Assembly in 2015 (Tangcharoensathien, Mills, & Palu, 2015), and achievement of universal 
health coverage remains high on the global health agenda. 
 
Taiwan introduced a National Health Insurance Program in 1995 when around 40 percent of 
its population had no health insurance coverage. The programme attained a population 
coverage beyond 90 percent in its first year and has subsequently reached and maintained a 
coverage of over 99 percent, with services characterised by high levels of overall patient 
satisfaction (over 80%), short waiting times, and flexibility for individuals to choose their 
service providers (National Health Insurance Administration, 2018a). More remarkably, these 
milestones have been accomplished with a relatively modest expenditure compared with 
other countries that have well-established healthcare systems. The total spending on health 
was equivalent to 6.6 percent of Taiwan’s gross domestic product in 2012; this is lower than 
9.3 percent for the UK, 10.3 percent for Japan, and much lower than 16.9 percent for the US 
(T. Cheng, 2015; National Health Insurance Administration, 2016). This achievement has 
therefore drawn international attention as a good example that other countries could learn 
from (S. Cheng & Chiang, 1997; T. Cheng, 2003; Wen, Tsai, & Chung, 2008). 
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Notwithstanding these achievements, Taiwan’s National Health Insurance Program also faces 
ongoing challenges, including the financial pressure associated with the rising costs of care 
for an ageing population with low fertility, and overworked healthcare workforce (T. Cheng, 
2015; M. Yeh & H.-H. Chang, 2015). The exclusion from the WHA/WHO means that 
Taiwan was shut out of the world’s prime forum for health policy to share this successful 
experience with other countries and to discuss solutions for common challenges. 
 
2. Traditional Chinese Medicine 
A unique feature of Taiwan’s National Health Insurance Program is its inclusion of providers 
of both Western medicine and traditional Chinese medicine, with over 3,500 registered 
traditional Chinese medicine clinics (National Health Insurance Administration, 2018b). 
Although Western medicine has been the mainstream healthcare in Taiwan for decades, 
traditional Chinese medicine is practised and remains a popular option for many health 
conditions involving the respiratory, digestive, and genitourinary systems, as well as chronic 
pain (F. Chen, T. Chen, & Kung et al., 2007). The provision of Chinese medicine alongside 
Western medicine offers the Taiwanese population a wider choice to fulfil their health needs, 
but it has also raised some administrative and regulatory issues (H. Wang & C. Wang, 2018). 
As the WHO embraces traditional Chinese medicine by incorporating related terminology in 
the latest International Classification of Diseases 11th Revision (ICD-11) (Cyranoski, 2018), 
which is a widely adopted international standard for classifying and coding diseases and 
health-related problems, the practice and uptake of traditional Chinese medicine is set to 
continue spreading around the world. At the same time, scepticism regarding the 
effectiveness, safety, and mechanisms of action of traditional Chinese medicine remains 
among practitioners of evidence-based medicine (Cyranoski, 2018). Further dialogues 
between relevant stakeholders and collection of sound evidence from well-designed research 
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and real-life practice will be crucial to resolve uncertainties and ensure future development 
that maximises the population’s health gain. The inclusion of both traditions of medical 
practice, education, and research in Taiwan’s healthcare system will provide a unique 
opportunity for these activities (F. Chen et al., 2007). Indeed, a comprehensive database 
covering more than 20,000 pure compounds isolated from 453 traditional Chinese medicine 
ingredients has been created by Taiwanese researchers (C. Y. Chen, 2011). 
 
3. Migrant Health (Healthcare for Foreign Workers and Immigrants) and 
International Travel 
With an estimated 8.2 births per 1,000 of the population per year, Taiwan has one of the 
lowest birth rates in the world (Central Intelligence Agency, 2019). Coupled with a rapidly 
ageing population, there is a need for additional workforce that cannot be met by its native 
population in many sectors, including manufacturing, agriculture, and health and social care. 
Consequently, a sizeable population of foreign workers have come to work in Taiwan, 
primarily from neighbouring countries, including Indonesia, Vietnam, the Philippines, and 
Thailand. The number has been rising steadily from around 300,000 in 2003 to nearly 
700,000 in 2018 (Ministry of Labor, 2018). In addition, hundreds of thousands of immigrants 
associated with international marriage, mostly women from mainland China and Southeast 
Asian countries, have settled in Taiwan since the late 1980s (Jones & Shen, 2008; Yang, H. 
Wang, & F. Lee et al., 2015). The healthcare needs of these foreign nationals and immigrants 
are covered by, and therefore dependent upon, the National Health Insurance Program 
previously mentioned. 
 
Taiwan also has an active and growing tourism industry. In 2015 alone, there were over 10 
million visitor arrivals, with over half arriving from mainland China, Hong Kong, or Macao; 
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over 1.6 million from Japan; 1.4 million from Southeast Asian countries; approximately 
588,000 from the Americas; 274,000 from Europe; 90,000 from Oceania; and 10,000 from 
Africa (Tourism Bureau Ministry of Transport and Communication, 2016). In the same year, 
there were over 13 million outbound departures by citizens of Taiwan, with Japan (3.7 
million), mainland China (3.4 million), and Hong Kong (2 million) being the most frequent 
first destinations. The large volume of international air travel has major implications on 
Taiwan’s need to be an indispensable member of the international network for communicable 
disease surveillance and control, as described later in this paper. 
 
Infectious Disease Control and Prevention 
 
1. Viral Hepatitis 
Chronic liver diseases associated with viral infection remain a major public health challenge. 
It was estimated that in 2015 alone viral hepatitis caused 1.34 million deaths worldwide—an 
impact on mortality similar to that of tuberculosis and greater than HIV (WHO, 2017). The 
burden of the hepatitis B virus (HBV) infection is particularly high in Africa and Eastern 
Asia/Western Pacific regions. Taiwan has led the way in research to combat HBV. An early 
population study from Taiwan back in the 1980s established the strong link between the HBV 
infection and liver cancer (Beasley, C. Lin, & Hwang et al., 1981). A mass vaccination 
programme, firstly targeted at infants of mothers who were HBV carriers, also demonstrated 
its feasibility (D. Chen, N. Hsu, & J.-L. Sung et al., 1987) and effectiveness (H. Hsu, D. 
Chen, & C. Chuang et al., 1988). This was followed by successive expansions of the 
immunisation programme to cover all neonate, children of older ages and eventually adults, 
with a corresponding reduction in population incidence of the hepatitis B viral infection (H. 
Chen, M. Chang, & Ni et al., 1996; Ni, L. Huang, & M. Chang et al., 2007) and liver cancer 
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(M. Chang, C. Chen, & Lai et al., 1997) clearly documented. Backed by the strong evidence, 
mass immunisation programmes were subsequently adopted by many other countries and 
were recommended by the WHO (WHO, 2017). Taiwan is now stepping up its effort to 
eliminate hepatitis C (G. Wu, Pwu, & S. Chen, 2018), another major threat to public health 
highlighted by the WHO. 
 
2. Influenza 
Influenza causes discomforting symptoms and may lead to severe illness, particularly among 
vulnerable groups such as very young children, pregnant women, the elderly, and people with 
chronic health conditions (WHO, 2012). It is estimated to be associated with approximately 
between 290,000 to 650,000 deaths globally each year (Iuliano, Roguski, & H. Chang et al., 
2018). The disease, caused by a family of influenza viruses, is difficult to contain as it can be 
spread easily through droplets carrying the virus, which are spread into the air by coughs and 
sneezes. The contagiousness combined with the high level of morbidity and mortality 
associated with influenza, including infrequent but potentially devastating pandemic 
outbreaks, make its prevention and control a high priority. Prompt identification and effective 
quarantine and isolation of the infected person remain the key measures to contain the disease 
and its impact. In order to address this major global challenge, the WHO has coordinated a 
Global Influenza Surveillance and Response System (formerly known as Global Influenza 
Surveillance Network) since 1952 (WHO, 2019). 
 
Although influenza vaccines have been developed, the protection conferred by these vaccines 
varies by year and location because of the high level of genetic mutation of the viruses 
(WHO, 2012). The advice on vaccine composition is issued yearly following consultation 
with members of WHO Collaborating Centres on Influenza and Essential Regulatory 
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Laboratories. Manufacturers of influenza and many other vaccines also rely on the supply of 
certified ‘reference viruses’ and reagents for vaccine standardisation. Despite being one of 
the first Asian countries to qualify for the membership of the Pharmaceutical Inspection Co-
operation Scheme (PIC/S), a leading organisation for international development, 
implementation, and maintenance of harmonised Good Manufacturing Practice standards 
concerning medicinal products, Taiwan’s lack of WHO membership means site visits and 
certification by WHO cannot be arranged. It also means that the vaccines it is capable of 
producing cannot be sent to other countries in need to ease vaccine shortage. These have 
important public health implications for the preparedness of pandemic influenza. 
 
3. Severe Acute Respiratory Syndrome 
While influenza has been an ongoing, major threat to public health, serious illnesses caused 
by other contagious viruses have emerged since the turn of the new millennium. The severe 
acute respiratory syndrome (SARS) caused by a coronavirus is an example that underscores 
the unprecedented challenge that health authorities around the world face in an era when a 
disease can be carried and spread from one country to another country thousands of miles 
away within a day. The case of SARS also vividly illustrated the adversity and hardship that 
people in Taiwan experienced when they faced the emergence of such a terrifying condition 
without having direct access to the WHO, an organisation that was set up to deal with very 
situations like this. 
 
Since November 2002, cases of an atypical pneumonia started to appear in China’s southern 
province of Guangdong (Zhong, Zheng, & Li et al., 2003). A major outbreak of similar cases 
occurred in March 2003 in neighbouring Hong Kong, from where the disease was believed to 
have further spread to other countries including Singapore, Vietnam, and Taiwan in Southeast 
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Asia, and as far as Canada within a month (Hui & J. Sung, 2003). Faced with a hitherto 
unknown disease spreading rapidly around the world and causing serious illness and deaths, 
the WHO issued a global alert on 12 March 2003 and coordinated global collaborative 
networks to identify the underlying pathogen, develop tools for its diagnosis, survey ongoing 
and new cases, explore treatment options, and contain the further spread of the disease 
(WHO, 2003). Within a few weeks, a new coronavirus was identified as the cause of the 
disease. Advice for international travel and screening of suspected cases was issued, and a 
global surveillance system for the disease was proposed. Outbreaks in various countries and 
regions peaked and were brought under control in the following months. By July 2003, the 
WHO announced that the last person-to-person chain of transmission of the SARS virus had 
been broken following removal of Taiwan from its list of areas with recent local transmission 
(Drosten, Lau, & Preiser et al., 2003). Overall, over 8,000 cases of SARS leading to more 
than 700 deaths were reported worldwide, but fortunately, the phenomenal global effort 
seems to have prevented the much worse scenario that had been anticipated. 
 
Behind this success story, however, was the struggle for healthcare practitioners, researchers, 
and governmental officials in Taiwan, which suffered from the third largest outbreak after 
China and Hong Kong. They sought to join the collaborative networks set up by WHO and to 
obtain direct, timely access to crucial information, samples, and diagnostic materials without 
success due to Taiwan’s lack of WHO membership (Cyranoski, 2003). Researchers from 
Taiwan spoke of their frustration as they were unable to participate in the meetings between 
WHO’s Collaborating Centres and had to rely on information made available on WHO’s 
website: ‘By the time the information is in the public domain, it’s probably out of date’ 
(Cyranoski, 2003: 652). While Taiwan was able to obtain some assistance through unofficial 
routes from other international allies in the end, it was delayed by several weeks (Hickey, 
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2006). This was in contrast with the very purpose behind the international collaborative 
networks: ‘In outbreak alert and response, every hour counts, as the window of opportunity 
for preventing deaths and further spread closes quickly’ (World Health Organization 
Communicable Disease Surveillance and Response, 2003, emphasis added). Since the 
outbreak of SARS, further emerging viral diseases such as Middle East Respiratory 
Syndrome, Ebola, and Zika have hit news headlines and caused major concerns. In each case, 
collaborative international effort has undoubtedly contributed to the rapid identification of the 
cause and mechanisms of the diseases, the identification of new cases, and strategies for their 
treatment and prevention. Taiwan’s exclusion from key official organisations and networks 
associated with these functions presents an important threat to the international effort in 
controlling the risk posed by emerging infectious diseases, which not only threaten human 
health, but have far-reaching social and economic impacts (C. Ko, C. Yen, & J. Yen et al., 
2006; Qiu, Chu, & Mao et al., 2018). 
 
Biomedical Research 
Taiwan is an active member of the medical and health research community and has made a 
steady contribution towards the world’s biomedical literature. As a broad indicator, a 
keyword search of ‘Taiwan’ in PubMed yielded over 14,000 records indexed for 2017 alone. 
Researchers from Taiwan participated in landmark international collaborations such as the 
Global Burden of Disease Study (GBD 2013 Mortality and Causes of Death Collaborators, 
2015) that examined the prevalence and incidences of different diseases and their impact on 
morbidity and mortality across the globe. They also participated in the International HapMap 
Project (International Hapmap Consortium, 2003), which investigated common patterns of 
variation in DNA sequences in the human genome and made the information publicly 
available. 
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In the era of ‘big data’, the potential to learn from patterns and trends arising from the 
enormous amounts of data generated and stored in electronic formats (such as electronic 
hospital records and health insurance databases) and to use this information to advance 
science has been highlighted in many fields, including medical and health sciences. Taiwan 
has taken advantage of a nationwide information system established for the aforementioned 
National Health Insurance Program and created a National Health Insurance Research 
Database (NHIRD), which is one of the largest nationwide databases in the world (Y. Chen, 
H. Yeh, & J. Wu et al., 2011). The NHIRD allows linkage with other national databases such 
as those pertaining to household registry, birth/death certification, and cancer, and thus 
provides a unique resource for medical and health services research that few databases from 
other countries could match (Hsing & Ioannidis, 2015).  
 
While Taiwanese researchers and health professionals have strived for and have largely 
enjoyed full participation in international academic societies and meetings, political 
interferences have threatened their dignity and involvement, amid the Chinese government’s 
effort to supress Taiwan’s international presence (MOFA, 2018a; Strong, 2017). As 
illustrated earlier in the case of SARS, Taiwanese delegates, including scholars, have faced 
substantial hurdles in order to participate in technical meetings organised by WHO and 
related institutions. Under current practice (in which Taiwan has no say), Taiwan’s requests 
to WHO for participation are routed to China and are subject to its ‘approval’. Delays and 
rejections are common (MOFA, 2018a), and these severely hamper Taiwan’s involvement in 
decision-making related to global health and exchange of technical expertise with 
international partners. 
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Other Areas Related to Health 
The examples described above represent a small proportion of aspects among a vast number 
of the medical and health-related issues and activities that people in Taiwan engage with 
locally and globally on a daily basis. For example, Taiwan was among the first countries in 
Asia to introduce legislation related to sexual offences and domestic violence, and its efforts 
in health promotion has produced good results in the reduction of tobacco smoking and areca 
(betel) nut use. Areca nut use is strongly associated with oral cancer and is an important 
public health issue in several South Asian and Western Pacific countries. Taiwanese 
researchers have made a major contribution in understanding its epidemiology (C. Lee, A. 
Ko, & Warnakulasuriya et al., 2012) and in studying its negative health effects (Y. Ko, Y. 
Huang, & C. Lee et al., 1995; C. Lee, J. Lee, & D. Wu et al., 2005). Taiwan endures fierce 
typhoons (tropical storms) almost every year and has experienced several devastating 
earthquakes in the past. It therefore has local expertise in emergency response (including 
healthcare) to natural disasters that could be shared, but at the same time there are also 
unpredictable but urgent needs for Taiwan to receive help from other nations when these 
events strike. Taiwan’s timely reception and offering of such assistance from and to other 
countries has been hampered in several humanitarian crises by the lack of WHO membership 
in association with China’s objection (Hickey, 2006). 
 
With its good economic standing, Taiwan has made substantial financial contributions 
towards international cooperation and development in many parts of the world. In 2017 alone 
the amount exceeded US$321 million, including over US$24 million related to health and 
medical care and over US$28 million towards emergency humanitarian aids (MOFA, 2018b). 
While a large proportion of these funds was contributed to the small number of countries 
which have maintained an official tie with Taiwan, assistance related to health offered by 
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both the Taiwanese government and non-governmental organisations has covered well over 
70 countries around the world (Hickey, 2006), with recent examples including health 
emergencies such the Ebola outbreak (K. Lee & Fang, 2016) and ongoing training for 
healthcare providers from developing countries (for example, through the Taiwan 
International Healthcare Training Center). Charitable organisations, in collaboration with 
volunteer health professionals from Taiwan, regularly tour remote villages and deprived 
communities worldwide to provide humanitarian aid and free healthcare. In the past, Taiwan 
has suffered from environmental pollutions that have had direct adverse consequences for 
health during the period of rapid economic growth; important studies on environmental 
arsenic exposure were published on the basis of this unfortunate experience (C. Chen, L. Hsu, 
& H. Chiou et al., 2004; C. Chen, Y. Chuang, & T. Lin et al., 1985; H. Chiou, S. Chiou, & Y. 
Hsu et al., 2001). Taiwan is also not immune from the recent resurgence of dengue fever, a 
disease transmitted through mosquito bites that could be life-threatening (in its severe forms) 
and that has posed major threats in many Asian and Latin American countries (WHO, 2018). 
Many of the above issues are high on WHA’s agenda, and they further illustrate that Taiwan 




Despite having a population larger than that of two-thirds of the member states of the WHO, 
Taiwan continues to be excluded from this pivotal organisation, which leads and coordinates 
international efforts to improve global health, due to political reasons. This situation is in 
sharp contrast with the principle enshrined by the WHO in its 1946 Constitution: ‘the highest 
attainable standard of health as a fundamental right of every human being’ (WHO, 2006, 
emphasis added). This article has described how Taiwan has contributed to the advance of 
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medical and health services and research both locally and internationally during the decades 
of its exclusion from the WHA/WHO. Judging from the substantial achievement, it may 
appear, on the surface, that Taiwan’s lack of official recognition and membership has not had 
much negative impact on its ability to promote health and to interact with the international 
community. However, as highlighted in the cases here, difficulties are frequently encountered 
by Taiwanese officials (and increasingly by Taiwanese scholars) in relation to participation in 
international meetings, and crucial international support has been delayed or unavailable 
during emergency situations because of the lack of a direct, official channel to communicate 
with the WHO. In addition to the disadvantages and real threats towards health that are posed 
to people who live in and/or who have connection with Taiwan, its exclusion from the 
WHA/WHO has also led to many missed opportunities for Taiwan to share its social and 
economic resources and its rich experiences in creating advanced technologies and tackling 
health-related issues with the international community in a timely and efficient manner. The 
‘default’ position of being excluded from WHO/WHA-related activities over the decades 
might have also resulted in less apparent but more profound disadvantages for Taiwanese 
officials, health professionals, and scholars in terms of restricting their exposures to latest 
developments and training opportunities related to health sciences, technologies, and 
effective interventions, and limiting their vision in contemporary global health affairs and 
policy. As a past secretary of US Department of Health and Human Services put it, ‘the 
people of Taiwan deserve the same level of public health as citizens of every nation on earth’ 
(F. Lin, 2003). It is questionable why their basic entitlements are deprived despite the 
previously described contributions that they have made towards global health. 
 
In this close-knit modern world in which people, commodities (including foods and 
medicines), and information, as well as pathogens and pollutants, can move swiftly from one 
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part of the globe to another, the exclusion of Taiwan from WHA/WHO has impacts far 
beyond its own land and people, and should be a shared concern for all. Indeed, the 
international medical community has repeatedly voiced their concerns of the exclusion of 
Taiwan from the WHA/WHO (‘Not on the List’, 2017; ‘Taiwan: Time to End the Exile’, 
1999; World Medical Association, 2005). Due attention and support from the international 
community, as well as efforts from authorities on both sides of the Taiwan straits to forge a 
shared wisdom for the resolution of the unfortunate political situation shaped by past history, 
would be required to overcome the impasse and to enable Taiwan’s unconditional 
participation in this top health authority of the world. This would be consistent with the 
principle of health as a human right for all, and encourage global collaboration in health 
service delivery and health research, including those between Taiwan and mainland China 
that have already been occurring (‘Unchartered Territory’, 2011). 
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